Figure 6a.
Immunoreactivity intensity of IL-6 in each experimental group at 48 (*: p < 0.001 vs. control, **: p < 0.05 vs. prednisolone group, #: p < 0.05 vs. LPS group).
Immunoreactivity intensity of IL-6 in each experimental group at 48 (*: p < 0.001 vs. control, **: p < 0.05 vs. prednisolone group, #: p < 0.05 vs. LPS group).